Literature DB >> 16202389

The N-terminal half of talin2 is sufficient for mouse development and survival.

Nien-Tsu Chen1, Su Hao Lo.   

Abstract

Using a talin2 gene-trapped embryonic stem cell clone, we have developed a talin2 mutant mouse line that expresses the N-terminal half (1-1295) of talin2 fused with beta-galactosidase. The homozygous mutant mice appear to be normal and healthy. In the testis, talin2 expresses as a shorter form with a unique 30 residues at N-terminus linking to a common C-terminus from 1122 to 2453 of the long form. The resulting talin2 in the mutant testis only contains 204 residues of the wild-type testis talin2. However, it did not seem to affect the morphology of testis or reproduction of male mice. In fact, male and female mutant mice are fertile. Utilizing the expression of talin2(1-1295)/beta-galactosidase fusion protein, we have examined the distribution of talin2 in tissues. In contrast to talin1, talin2 expression is more restricted in tissues and cell types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202389     DOI: 10.1016/j.bbrc.2005.09.100

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Talin determines the nanoscale architecture of focal adhesions.

Authors:  Jaron Liu; Yilin Wang; Wah Ing Goh; Honzhen Goh; Michelle A Baird; Svenja Ruehland; Shijia Teo; Neil Bate; David R Critchley; Michael W Davidson; Pakorn Kanchanawong
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

Review 2.  Integrin inactivators: balancing cellular functions in vitro and in vivo.

Authors:  Daniel Bouvard; Jeroen Pouwels; Nicola De Franceschi; Johanna Ivaska
Journal:  Nat Rev Mol Cell Biol       Date:  2013-05-30       Impact factor: 94.444

3.  Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis.

Authors:  Jie Liu; Xiaowen He; Yanmei Qi; Xiaoxiang Tian; Susan J Monkley; David R Critchley; Siobhan A Corbett; Stephen F Lowry; Alan M Graham; Shaohua Li
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

4.  Desmoplakin and talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle.

Authors:  Samantha A Whitman; Cathleen Cover; Lily Yu; David L Nelson; Daniela C Zarnescu; Carol C Gregorio
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

5.  Contributions of talin-1 to glioma cell-matrix tensional homeostasis.

Authors:  Shamik Sen; Win Pin Ng; Sanjay Kumar
Journal:  J R Soc Interface       Date:  2011-12-07       Impact factor: 4.118

6.  The structure of an interdomain complex that regulates talin activity.

Authors:  Benjamin T Goult; Neil Bate; Nicholas J Anthis; Kate L Wegener; Alexandre R Gingras; Bipin Patel; Igor L Barsukov; Iain D Campbell; Gordon C K Roberts; David R Critchley
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

Review 7.  Vinculin and talin: focus on the myocardium.

Authors:  Alice Zemljic-Harpf; Ana Maria Manso; Robert S Ross
Journal:  J Investig Med       Date:  2009-12       Impact factor: 2.895

8.  Studies on the morphology and spreading of human endothelial cells define key inter- and intramolecular interactions for talin1.

Authors:  Petra M Kopp; Neil Bate; Tania M Hansen; Nicholas P J Brindle; Uta Praekelt; Emmanuel Debrand; Stacey Coleman; Daniela Mazzeo; Benjamin T Goult; Alexandre R Gingras; Catrin A Pritchard; David R Critchley; Susan J Monkley
Journal:  Eur J Cell Biol       Date:  2010-09       Impact factor: 4.492

9.  Phylogenetic analysis, expression patterns, and transcriptional regulation of human CTEN gene.

Authors:  Nien-Tsu Chen; Yasuko Kuwabara; Christopher Conley; Yi-Chun Liao; Shiao-Ya Hong; Michelle Chen; Yi-Ping Shih; Hong-Wu Chen; Fushing Hsieh; Su Hao Lo
Journal:  Gene       Date:  2013-03-14       Impact factor: 3.688

10.  Talin 2 is a large and complex gene encoding multiple transcripts and protein isoforms.

Authors:  Emmanuel Debrand; Yasmine El Jai; Lorraine Spence; Neil Bate; Uta Praekelt; Catrin A Pritchard; Susan J Monkley; David R Critchley
Journal:  FEBS J       Date:  2009-02-07       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.